Search Results
Stopping Ibrutinib Therapy for CLL After 6 Years
Case 3: Managing Ibrutinib-Associated Toxicities in CLL
CLL: Long-term updates on ibrutinib and idelalisib
Phase Ib trial of ianalumab plus ibrutinib for CLL
Case 2: 17p-Deleted CLL Progressing on Ibrutinib Therapy
Overcoming resistance in CLL
The latest CLL treatments and therapies with Dr Jan Burger
Added ibrutinib in first-line CLL treatment
Grand Rounds 2020.05.20
Ibrutinib plus Venetoclax for first-line treatment of chronic lymphocytic leukaemia
Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL
Real-world use of ibrutinib in CLL
